Is There a Place or a Future for Antioxidant Therapy in COPD?

Oxygen-derived metabolites (ODM) are involved in the pathophysiology of numerous lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), or infection (1). The current knowledge of molecular mechanisms, sites, and conditions of production of these reactive species led to the hope of new therapeutic approaches. This has not been verified yet, but it still may be an important issue in the near future.